Dr. Pepper Snapple Inc. DPS manufactures and distributes some of the most popular carbonated soft drinks and non carbonated beverage brands in the U.S. It holds the #1 position in the flavored non-cola CSD market in the U.S. with a market share of almost 40% in the U.S. Dr Pepper soft drink, its most popular CSD brand, holds the #2 position in the flavored CSD market in the U.S.
Dr Pepper delivered a strong performance in 2014 driven by pricing gains, innovations, powerful marketing programs and productivity improvements. Moreover, it began 2015 on a strong note beating the Zacks Consensus Estimate for both earnings and revenues in the first quarter. However, growing health and wellness consciousness have been hurting its CSD sales, including the diet versions.
Due to this, investors are eagerly awaiting DPS’ earnings report in order to set the record straight and to give guidance for the company’s outlook.
Investors should however note the recent earnings estimate revisions for DPS as the consensus estimate has been moving upwards. Moreover, DPS has solid history when it comes to recent earnings reports as the stock has posted positive surprises in the last four quarters with an average surprise of 5.46%.
Currently, DPS has a Zacks Rank #2 (Buy), but that could change following Dr. Pepper’s earnings report which was just released. We have highlighted some of the key stats from this just-revealed announcement below:
Earnings: DPS beat on earnings. Our consensus earnings estimate called for EPS of $1.04 per share, and the company reported EPS of $1.08 instead. Investors should note that these figures take out stock option expenses.
Revenues: DPS reported revenues of $1.63 billion. This was in line with our consensus estimate of $1.59 billion.
Key Stats to Note: Sales Volume increased 3% during the quarter.
Stock Price: Inactive in pre-market trading.
Check back later for our full write up on this DPS earnings report later.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment